Back to Search
Start Over
Fibrosis mechanistic phenotyping and antifibrotic response determination with biomarkers in heart failure: one single biomarker may not fit all settings
- Source :
- European Journal of Heart Failure, European Journal of Heart Failure, Oxford University Press (OUP), 2018, 20 (9), pp.1300-1302. ⟨10.1002/ejhf.1214⟩, European Journal of Heart Failure, European Society of Cardiology (Wiley), 2018, 20 (9), pp.1300-1302. ⟨10.1002/ejhf.1214⟩
- Publication Year :
- 2018
- Publisher :
- HAL CCSD, 2018.
-
Abstract
- International audience; Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial. [Eur J Heart Fail. 2018]
- Subjects :
- [SDV] Life Sciences [q-bio]
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology
spironolactone
[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
[SDV]Life Sciences [q-bio]
heart failure
myocardial fibrosis
ComputingMilieux_MISCELLANEOUS
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
Subjects
Details
- Language :
- English
- ISSN :
- 13889842
- Database :
- OpenAIRE
- Journal :
- European Journal of Heart Failure, European Journal of Heart Failure, Oxford University Press (OUP), 2018, 20 (9), pp.1300-1302. ⟨10.1002/ejhf.1214⟩, European Journal of Heart Failure, European Society of Cardiology (Wiley), 2018, 20 (9), pp.1300-1302. ⟨10.1002/ejhf.1214⟩
- Accession number :
- edsair.dedup.wf.001..07adef3058f2ef347fdd8103a3a87af9